Compare VFF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | EMBC |
|---|---|---|
| Founded | 1989 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.2M | 207.1M |
| IPO Year | 2013 | 2021 |
| Metric | VFF | EMBC |
|---|---|---|
| Price | $1.99 | $3.20 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | 1.1M | ★ 2.5M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | ★ 184.38 | 20.90 |
| EPS | 0.02 | ★ 0.67 |
| Revenue | ★ $215,937,000.00 | N/A |
| Revenue This Year | $12.19 | $1.17 |
| Revenue Next Year | $15.82 | N/A |
| P/E Ratio | $99.50 | ★ $4.76 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.27 | $2.77 |
| 52 Week High | $4.99 | $15.55 |
| Indicator | VFF | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 40.00 |
| Support Level | $1.81 | $3.01 |
| Resistance Level | $2.10 | $3.48 |
| Average True Range (ATR) | 0.10 | 0.17 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 61.02 | 36.73 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.